William Eaglstein, M.D., . is a medical graduate of the University of Missouri, Columbia. After an internship at Kings County Hospital in Brooklyn he completed his dermatology training at the University of Miami followed by service in the U.S. Navy Medical Corps.
He is a past professor and chairman of dermatology at the University of Pittsburgh and the University of Miami, where he is currently chairman emeritus. Since 2004 he has worked in industry at Ivax Pharmaceuticals (President of Ivax Derm), Teva and Stiefel Pharmaceuticals ( Vice President of Research ) and Stiefel a GSK company (Vice President of New Product Assessment and External Research).
Dr. Eaglstein has been a Robert Wood Johnson Health Policy Fellow, Chairman of an FDA skin advisory panel and on the National Institute of Arthritis, Musculoskeletal and Skin Diseases Advisory Panel and now serves on the NIAMS Clinical Trials Review Committee. He is currently an independent consultant and serves as a volunteer for the Stanford School of Medicine SPARK program.
Dr. Eaglstein is a founding trustee of Advancing Innovation in Dermatology.
Dermatology is recognized as a burgeoning area with exciting innovation for patients, doctors, and investors.
Pascale Communications was on the scene at the annual American Academy of Dermatology (AAD).
DENVER — R. Rox Anderson, MD, professor of dermatology at Harvard Medical School and director of the Wellman Center for …